Loading…
Tiziana Life Sciences Ltd is projected to decline to $1.02 by 2027, a -1% move from its current price of $1.03. TLSA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $0.9823 | $1.03 | $1.08 | +0.02% |
| Aug 5 | $0.9634 | $1.03 | $1.10 | +0.04% |
| Aug 6 | $0.9491 | $1.03 | $1.12 | +0.07% |
| Aug 7 | $0.9373 | $1.03 | $1.13 | +0.09% |
| Aug 8 | $0.927 | $1.03 | $1.15 | +0.11% |
| Aug 9 | $0.9179 | $1.03 | $1.16 | +0.13% |
| Aug 10 | $0.9095 | $1.03 | $1.17 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9095 | $1.03 | $1.17 | +0.16% |
| Week 2 | $0.8647 | $1.03 | $1.23 | +0.31% |
| Week 3 | $0.832 | $1.03 | $1.29 | +0.47% |
| Week 4 | $0.8057 | $1.04 | $1.33 | +0.63% |
| Week 5 | $0.7833 | $1.04 | $1.38 | +0.79% |
| Week 6 | $0.7637 | $1.04 | $1.42 | +0.95% |
| Week 7 | $0.7463 | $1.04 | $1.45 | +1.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tiziana Life Sciences Ltd is a healthcare company focused on research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is in Phase II clinical trials for non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis. The company also develops TZLS-501, a human anti-IL-6R monoclonal antibody for autoimmune and inflammatory diseases.
The group is headquartered in London, United Kingdom.
TLSA is currently trading in the healthcare space with a market capitalization of $123.09M and a market rank of 3909. The stock’s price is $0.9672, providing a positioning that investors may weigh against its clinical-stage pipeline and regulatory trajectory.
A major floor 37.5% below — a decisive break under it would weaken the trend.
The nearest floor, 13.6% below — buyers have tended to step in here.
The nearest ceiling, 29.1% above — a clean break opens room to run.
A major ceiling 56.3% above — clearing it would confirm fresh momentum.
Key TLSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TLSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.968 | Buy | $0.9859 | Buy |
| MA 10 | $0.972 | Buy | $1.00 | Buy |
| MA 20 | $1.09 | Sell | $1.06 | Sell |
| MA 50 | $1.19 | Sell | $1.16 | Sell |
| MA 100 | $1.25 | Sell | $1.25 | Sell |
| MA 200 | $1.44 | Sell | $1.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.64 | Neutral |
| Stoch RSI (14) | 74.38 | Neutral |
| CCI (20) | -32.56 | Neutral |
| Williams %R (14) | -60.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -7.21 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 40.00 | Neutral |
| TRIX (15) | -0.79 | Sell |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 49.97 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 0.98 | Buy |
| ADX (14) | 17.97 | Neutral |
| ATR (14) | 0.05 | Info |
The near-term technical picture is BEARISH, with RSI(14) at 40. The price levels show a short-term struggle around key moving averages: the SMA50 is $1.23 and the SMA200 is $1.46. Support is noted at $0.89 and resistance at $1.33. The stock has traded within a 30-day range from $0.6947 to $1.35.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.89 | $1.03 | $1.30 | 0% | Neutral | |
| $0.7617 | $1.02 | $1.48 | -1% | Neutral | |
| $0.789 | $1.12 | $1.72 | +9% | Neutral | |
| $0.6774 | $1.01 | $1.62 | -2% | Neutral | |
| $0.8149 | $1.26 | $2.10 | +22% | Bullish | |
| $1.03 | $1.65 | $2.85 | +60% | Bullish | |
| $1.04 | $1.72 | $3.06 | +67% | Bullish | |
| $1.12 | $1.93 | $3.51 | +87% | Bullish | |
| $0.9806 | $1.74 | $3.25 | +69% | Bullish | |
| $0.877 | $1.61 | $3.07 | +56% | Bullish | |
| $1.34 | $2.87 | $5.97 | +178% | Bullish | |
| $1.85 | $4.10 | $9.44 | +299% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.89 | $1.03 | $1.22 | +0.00% |
| September 2026 | $0.8445 | $1.02 | $1.28 | -0.91% |
| October 2026 | $0.8593 | $1.05 | $1.35 | +3.01% |
| November 2026 | $0.8176 | $1.01 | $1.31 | -3.90% |
| December 2026 | $0.7942 | $0.9904 | $1.30 | -1.97% |
Click any year to see its month-by-month TLSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TLSA to range from $0.89 to $1.30 through 2026. The $1.03 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The TLSA price prediction for 2027 points to an average of $1.02 (low $0.7617, high $1.48) — a potential decline of -1% on today's $1.03. Price action looks broadly range-bound.
In 2028, TLSA is projected to trade between $0.789 and $1.72, averaging $1.12 — a potential gain of +9% from today's $1.03. That is up +9% on the projected 2027 average. A consolidation phase looks the most probable path here.
Tiziana Life Sciences Ltd's 2029 outlook centres on $1.01, within a $0.6774 to $1.62 range. That is -10% versus the projected 2028 average. That marks a -2% change versus current levels. Price action looks broadly range-bound.
By 2030, TLSA could reach as high as $2.10, with a base case around $1.26 and support toward $0.8149 — roughly +22% from $1.03. Buyers look set to stay in control over this stretch.
Expect TLSA to range from $1.03 to $2.85 through 2031. The $1.65 average target implies a +60% move from current prices. That is up +31% on the projected 2030 average. Momentum favours further upside here.
The TLSA price prediction for 2032 points to an average of $1.72 (low $1.04, high $3.06) — a potential gain of +67% on today's $1.03. Buyers look set to stay in control over this stretch.
In 2033, TLSA is projected to trade between $1.12 and $3.51, averaging $1.93 — a potential gain of +87% from today's $1.03. That is up +12% on the projected 2032 average. Momentum favours further upside here.
Tiziana Life Sciences Ltd's 2034 outlook centres on $1.74, within a $0.9806 to $3.25 range. That is -10% versus the projected 2033 average. That marks a +69% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, TLSA could reach as high as $3.07, with a base case around $1.61 and support toward $0.877 — roughly +56% from $1.03. Momentum favours further upside here.
Expect TLSA to range from $1.34 to $5.97 through 2040. The $2.87 average target implies a +178% move from current prices. That is up +78% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The TLSA price prediction for 2050 points to an average of $4.10 (low $1.85, high $9.44) — a potential gain of +299% on today's $1.03. Momentum favours further upside here.
Investing $1,000 in TLSA today (≈ 970.873786 TLSA) could be worth
$3,985.37
+$2,985.37 (+299%) by 2050 · US Dollar
Based on the average projected TLSA price of $4.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TLSAwould be worth at today's price.
$1,000 invested in TLSA on Jul 31, 2025 (≈ 400 TLSA) would be worth
$412
-$588 (-58.8%) today · 0.41× · US Dollar
Based on a TLSA entry price of $2.5 vs. today's $1.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.89 | $1,157.3 | +15.7% |
| 1 month ago | $1.23 | $837.4 | -16.3% |
| 3 months ago | $1.34 | $768.66 | -23.1% |
| 6 months ago | $1.44 | $715.28 | -28.5% |
| 1 year ago | $2.5 | $412 | -58.8% |
| All time (5.0y) ago | $2.08 | $495.19 | -50.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TLSA forecast.
Our base-case forecast reaches $2.10 around 2040.
Implied market cap at $2.10: $267.24M
The multi-year forecast portrays a path from neutral to bullish momentum over time. In 2026 the avg price is $0.9672 with a min of $0.89 and a max of $1.23 and 0% ROI. In 2031–2050 the outlook strengthens, with 2031 avg $1.47 (ROI 52%), 2032 avg $1.55 (ROI 60.5%), 2033 avg $1.72 (ROI 78.2%), 2034 avg $1.53 (ROI 58.2%), and 2035 avg $1.42 (ROI 46.7%).
By 2040, the avg price is $2.48 (ROI 156.8%), and by 2050 the avg price reaches $3.50 (ROI 262.4%), with the max projected around $5.29 in 2040 and $8.06 in 2050. Across this horizon, the forecast consistently marks bullish sentiment from 2031 onward, though near-term years include neutral stance and occasional downsides (e.g., 2027 ROI -1.7%, 2029 ROI -6.7%), underscoring the higher volatility implied by an annualized volatility of 100%.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $1.12, with a min of $0.7095 and a max of $1.90, and a ROI of 15.6%. The sentiment is NEUTRAL.
TLSA is current priced at $0.9672 with a market capitalization of $123.09M.
From 2031 onward the outlook is BULLISH, with 2031 avg $1.47 and 2050 avg $3.50, and ROI reaching up to 262.4%.
The 30-day technical picture is BEARISH with RSI(14) at 40. SMA50 is $1.23 and SMA200 is $1.46. There is support at $0.89 and resistance at $1.33. The 30-day range spans $0.6947 to $1.35.
The forecast shows a max of $8.06 in 2050, with an avg of $3.50 and a min of $1.58, and a ROI of 262.4% in that year, with sentiment BULLISH.
Tiziana Life Sciences Ltd Community Discussion
0Share your Tiziana Life Sciences Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.